The potential role of sensory testing, skin biopsy, and functional brain imaging as biomarkers in chronic pain clinical trials: IMMPACT considerations

Shannon M. Smith*, Robert H. Dworkin, Dennis C. Turk, Ralf Baron, Michael Polydefkis, Irene Tracey, David Borsook, Robert Edwards, Richard E. Harris, Tor D. Wager, Lars Arendt-Nielsen, Laurie B. Burke, Daniel B. Carr, Amy S. Chappell, John T. Farrar, Roy Freeman, Ian Gilron, Veeraindar Goli, Juergen Haeussler, Troels JensenNathaniel P. Katz, Jeffrey Kent, Ernest A. Kopecky, David A. Lee, William Maixner, John D. Markman, Justin C. McArthur, Michael P. McDermott, Lav Parvathenani, Srinivasa N. Raja, Bob A. Rappaport, Andrew S C Rice, Michael C. Rowbotham, Jeffrey K. Tobias, Ajay D. Wasan, James Witter

*Corresponding author

Research output: Contribution to journalReview articlepeer-review

47 Citations (Scopus)
Original languageEnglish
JournalJournal of Pain
Volume18
Issue number7
Pages (from-to)757-777
ISSN1526-5900
DOIs
Publication statusPublished - 2017

Keywords

  • Biomarkers
  • Brain imaging
  • IMMPACT
  • Sensory testing
  • Skin punch biopsy

Fingerprint Dive into the research topics of 'The potential role of sensory testing, skin biopsy, and functional brain imaging as biomarkers in chronic pain clinical trials: IMMPACT considerations'. Together they form a unique fingerprint.

Cite this